Lakewood Asset Management’s Renalytix plc American Depositary Shares RNLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-1,000
Closed -$2K 310
2022
Q4
$2K Buy
+1,000
New +$1.56K ﹤0.01% 306

Other funds holding RNLX

Lakewood Asset Management's RNLX Position: Q1 2023 in Review

Lakewood Asset Management sold out of Renalytix plc American Depositary Shares (RNLX) in Q1 2023, closing a stake of 1,000 shares — an estimated $2K sold.

Lakewood Asset Management first reported a position in RNLX in Q4 2022 and held it in 1 quarter. The position peaked at $2K in Q4 2022. 18 funds tracked by Wall St. Rank hold RNLX as of Q1 2023.

  • Lakewood Asset Management reported no remaining Renalytix plc American Depositary Shares position as of Q1 2023 after selling out during the quarter.
  • Lakewood Asset Management sold 1,000 Renalytix plc American Depositary Shares shares in Q1 2023, an estimated $2K.
  • Lakewood Asset Management first reported a position in Renalytix plc American Depositary Shares in Q4 2022 and held it in 1 quarter.
  • Lakewood Asset Management's Renalytix plc American Depositary Shares position peaked at $2K in Q4 2022.
  • 18 funds tracked by Wall St. Rank held Renalytix plc American Depositary Shares as of Q1 2023.

Based on Lakewood Asset Management's 13F filing for Q1 2023, filed 13 Apr 2023.